|
Q2 FY2027
As of Aug 1, 2026
|
Q1 FY2027
As of May 2, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Nov 1, 2025
|
Q2 FY2026
As of Aug 2, 2025
|
Q1 FY2026
As of May 3, 2025
|
Q4 FY2025
As of Feb 1, 2025
|
Q3 FY2025
As of Nov 2, 2024
|
Q2 FY2025
As of Aug 3, 2024
|
Q1 FY2025
As of May 4, 2024
|
Q4 FY2024
As of Feb 3, 2024
|
Q3 FY2024
As of Oct 28, 2023
|
Q2 FY2024
As of Jul 29, 2023
|
Q1 FY2024
As of Apr 29, 2023
|
Q4 FY2023
As of Jan 28, 2023
|
Q3 FY2023
As of Oct 29, 2022
|
Q2 FY2023
As of Jul 30, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 29, 2022
|
Q3 FY2022
As of Oct 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Accrued payroll and payroll taxes | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, no par value, 50,000 shares authorized; 15,854 shares issued and outstanding at August 1, 2026 and 16,971 shares issued and outstanding at January 31, 2026 | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
